Literature DB >> 21198395

Spectrum of CFTR gene mutations in Iranian Azeri Turkish patients with cystic fibrosis.

Mortaza Bonyadi1, Omid Omrani, Mandana Rafeey, Nemat Bilan.   

Abstract

AIMS: Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. In the present study, for the first time, we determined the spectrum of CFTR gene mutations in 100 patients with CF originated from the Iranian Azeri Turkish ethnic group.
RESULTS: Here, we report identification of 17 previously known and one novel mutation, namely K1302X, in this cohort. The frequency of deltaF508 mutation was found to be 23%.
CONCLUSIONS: Low frequency of deltaF508 mutation and detection of one novel and 16 known mutations reflect a heterogeneous spectrum of the mutations in this ethnic group.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21198395     DOI: 10.1089/gtmb.2010.0091

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  8 in total

1.  Minimum data set for cystic fibrosis registry: a case study in iran.

Authors:  Leila R Kalankesh; Saeed Dastgiri; Mandana Rafeey; Narmin Rasouli; Leila Vahedi
Journal:  Acta Inform Med       Date:  2015-02-22

2.  Association of TNF-α Gene Variants With Clinical Manifestation of Cystic Fibrosis Patients of Iranian Azeri Turkish Ethnicity.

Authors:  Aziz Khorrami; Mortaza Bonyadi; Mandana Rafeey; Omid Omrani
Journal:  Iran J Pediatr       Date:  2015-02-21       Impact factor: 0.364

3.  Next generation sequencing to determine the cystic fibrosis mutation spectrum in Palestinian population.

Authors:  O Essawi; M Farraj; K De Leeneer; W Steyaert; K De Pauw; A De Paepe; K Claes; T Essawi; P J Coucke
Journal:  Dis Markers       Date:  2015-01-26       Impact factor: 3.434

4.  Association Between Outcomes and Demographic Factors in an Azeri Turkish Population With Cystic Fibrosis: A Cross-Sectional Study in Iran From 2001 Through 2014.

Authors:  Leila Vahedi; Morteza Jabarpoor-Bonyadi; Morteza Ghojazadeh; Hakimeh Hazrati; Mandana Rafeey
Journal:  Iran Red Crescent Med J       Date:  2016-01-06       Impact factor: 0.611

5.  Novel CFTR Mutations in Two Iranian Families with Severe Cystic Fibrosis.

Authors:  Marzieh Mohseni; Mohammad Razzaghmanesh; Elham Parsi Mehr; Hanieh Zare; Maryam Beheshtian; Hossein Najmabadi
Journal:  Iran Biomed J       Date:  2016-03-27

6.  Gender Differences in Clinical Presentations of Cystic Fibrosis Patients in Azeri Turkish Population.

Authors:  Leila Vahedi; Morteza Jabarpoor-Bonyadi; Morteza Ghojazadeh; Amir Vahedi; Mandana Rafeey
Journal:  Tuberc Respir Dis (Seoul)       Date:  2016-10-05

7.  Phenotypic spectrum and genetic heterogeneity of cystic fibrosis in Sri Lanka.

Authors:  Neluwa Liyanage Ruwan Indika; Dinesha Maduri Vidanapathirana; Hewa Warawitage Dilanthi; Grace Angeline Malarnangai Kularatnam; Nambage Dona Priyani Dhammika Chandrasiri; Eresha Jasinge
Journal:  BMC Med Genet       Date:  2019-05-24       Impact factor: 2.103

8.  Clinical and genetic features in patients with cystic fibrosis in southwestern iran.

Authors:  Shirin Farjadian; Mozhgan Moghtaderi; Sara Kashef; Soheila Alyasin; Khadijehsadat Najib; Forough Saki
Journal:  Iran J Pediatr       Date:  2013-04       Impact factor: 0.364

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.